The MAPK Pathway as a Therapeutic Target in Cancer Research

Article   Nov 30, 2017 | by Jack Rudd, Senior Editor for Technology Networks

 
The MAPK Pathway as a Therapeutic Target in Cancer Research

Jack Rudd

Managing Editor

 
 
 

RELATED ARTICLES

Metagenomics: Exploring Microbiomes at Nature’s New Frontiers

Article

Advances in sequencing technologies are providing scientists with a powerful way to view microbial communities in unprecedented detail. Metagenomics is a rapidly evolving field that is uncovering a wealth of hidden biodiversity, revolutionizing our understanding of uncharted corners in the living world.

READ MORE

Advances in Fragment-Based Drug Discovery

Article

Over the past decade, fragment-based drug discovery has garnered increasing interest among drug discovery experts and has established itself as a key approach within the field – acting as an alternative starting point for the discovery of high-quality lead candidates. This article discusses the evolution of FBDD, highlights key drug discoveries, and explores the advantages and challenges of harnessing this approach

READ MORE

Exploiting the Tumor Microenvironment for Cancer Therapeutics

Article

It’s more than a century since Paget first proposed the ‘soil and seed’ hypothesis in cancer, providing evidence that the environment surrounding a tumor is as important as the tumor itself. After a landmark study in 2006 showed that immune cells, not tumor cells, are a better predictor of bowel cancer prognosis, research in this area has gathered momentum and it’s now the focus of intense research efforts.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE